[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma].
Haas
R
R
Radiologische Universitätsklinik, Heidelberg.
Moos
M
M
Karcher
A
A
Möhle
R
R
Witt
B
B
Goldschmidt
H
H
Flentje
M
M
Wannenmacher
M
M
Hunstein
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003596:Cytosine / Q000627:therapeutic use; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007937:Leukapheresis; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008942:Mitoxantrone / Q000627:therapeutic use; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction; D033581:Stem Cell Transplantation; D014916:Whole-Body Irradiation
D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D003596:Cytosine; D003520:Cyclophosphamide; D008942:Mitoxantrone; D000069585:Filgrastim